Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
SLC25A13 Prenatal Sequence Analysis (GeneAware) (Prenatal Sequence Analysis) Baylor Genetics United States | 1 | 1 |
|
Mitochondrial Panel, Nuclear genes CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 145 | 134 |
|
Al Jalila Children's Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 23 | 23 |
|
Hereditary hepatic diseases (55 genes) Center for Human Genetics Cliniques Universitaires Saint Luc Belgium | 36 | 55 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Hyperammonemia and Urea Cycle Disorder NGS Panel Fulgent Genetics United States | 70 | 56 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
Beacon Expanded Male Carrier Screening Plus Panel Fulgent Genetics United States | 661 | 306 |
|
Beacon Expanded Female Carrier Screening Panel Fulgent Genetics United States | 690 | 326 |
|
Citrullinemia, type II (SLC25A13) Amsterdam UMC, Location AMC Laboratory Genetic Metabolic Diseases, LGMD Netherlands | 1 | 1 |
|
Urea Cycle Disorders , Panel Massive Sequencing (NGS) 8 Genes Reference Laboratory Genetics Spain | 9 | 8 |
|
Asper Biogene Asper Biogene LLC Estonia | 11 | 10 |
|
Asper Biogene Asper Biogene LLC Estonia | 1 | 1 |
|
Laboratorio de Genetica Clinica SL Spain | 2 | 1 |
|
Citrullinemia Type 2, Screening Mutations SLC25A13 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Citrullinemia Type 2, Sequencing SLC25A13 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
GeneAware Complete Panel Version 2 (Male) Baylor Genetics United States | 164 | 149 |
|
GeneAware Complete Panel Version 2 (Female) Baylor Genetics United States | 175 | 159 |
|
Blueprint Genetics Finland | 8 | 46 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.